VOTRIENT 200 mg/1

VOTRIENT 200 mg is a film-coated tablet containing pazopanib hydrochloride, used for targeted therapy in certain cancers. This medication is designed to inhibit specific proteins involved in cancer cell growth.

VOTRIENT 200 mg is primarily used in the treatment of advanced renal cell carcinoma and certain types of soft tissue sarcoma. Pazopanib hydrochloride works by targeting proteins that help cancer cells grow and spread. This medication is often considered when other treatments have not been effective or are no longer suitable.

Common effects of VOTRIENT 200 mg may include fatigue, nausea, and changes in hair color or texture. Some individuals may experience high blood pressure or diarrhea. It is important to discuss any persistent or severe effects with a healthcare provider.

VOTRIENT 200 mg should be handled with care, as it is intended for specific medical conditions. It is important to follow the advice of a healthcare professional regarding its use. Pregnant women or those planning to become pregnant should consult their doctor before taking this medication.

VOTRIENT 200 mg may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect liver function should be discussed with a healthcare professional.